Início › Câncer de Bexiga Não Invasivo Muscular › Texas
Ensaios clínicos de Câncer de Bexiga Não Invasivo Muscular em Texas
15 estudos para Câncer de Bexiga Não Invasivo Muscular estão buscando participantes em locais em Texas.
Cidades em Texas
Texto oficial do estudo (Inglês)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Urology Austin, Austin
- Urology Clinics of North Texas, Dallas
- Baylor College of Medicine, Houston
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Texas Oncology-Austin, Austin
- Urology Austin, Austin
- Urology San Antonio PA dba USA Clinical Trials, San Antonio
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- e mais 5
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- UPNT Research Institute, Arlington
- UT Southwestern Medical Center, Dallas
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07309445Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- UT Southwestern Medical Center, Dallas
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05796375Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health Science Center at San Antonio, San Antonio
RecrutandoEstudo observacional
Idades de 18 a 99 · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05825950Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Urology Austin, LLC, Austin
- Houston Metro Urology, Houston
- e mais 2
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Houston Metro Urology, Houston
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
- MD Anderson Cancer Center, Houston
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
- Natera, Inc., Austin
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Urology Austin, Austin
- UT Southwestern Medical Center, Dallas
- Houston Metro Urology, Houston
- e mais 2
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
- UT Southwestern Medical Center, Dallas
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- University of Texas Southwestern Medical Center, Dallas
- Urology Partners of North Texas, Fort Worth
- Baylor College of Medicine, Houston
- e mais 2
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 27 de mai. de 2026 · NCT05710848Blue Light Cystoscopy With Cysview® Registry
- UT Southwestern, Dallas
- Michael E. DeBakey VA Medical Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 18 de dez. de 2025 · NCT02660645Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.